tirzepatide moldova Compounded MHRA grants authorisation for Lilly's

More frequent monitoring of international normalized ratio values may be necessary, particularly during tirzepatide initiation or dose adjustments

Patients should be educated about recognising hypoglycaemia symptoms (trembling, sweating, confusion, palpitations) and appropriate management strategies

In the SURMOUNT-1 trial, tirzepatide at the 15 mg dose produced average weight loss of 22.5 percent, with over one third of participants losing at least 25 percent of body weight

Proceedings of the National Academy of Sciences, 113 (27), 7650-7654

It is the first drug in this class of medications to be approved and released for type 2 diabetes and weight management

When using a telehealth service, you can book an online consultation from the comfort of your own home and get the medication prescribed online if it is right for you